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Introduction
The incidence of Cardiovascular Diseases (CVD) and its associated 
mortality is lower in premenopausal women compared to aged-
matched men, but increases rapidly after menopause and reaches 
similar level as in men (for review see [1]). These data suggest that 
17β-estradiol (estrogen, E2) prevents CVD in premenopausal women 
and contributes to the observed sex differences. Accordingly, several 
clinical studies and experimental animal settings showed that E2 
deficiency has been associated with an increased risk of mortality 
after cardiac injury, which was improved by E2 supplementation 
[2-4]. Experimentally, administration of E2 reduced infarct size and 
cardiomyocyte apoptosis [5-7], improved myocardial recovery and 
viability after Ischemia-Reperfusion (I/R) injury in different animal 
models [8-14]. The treatment with Estrogen Receptor (ER) antagonist 
ICI 182 780 reversed the E2-induced effects indicating that these effects 
are mediated by ER [8]. However, E2 and its receptor effects on the 
heart and vasculature are incompletely understood, and require a 
better basic understanding of the underlying mechanisms.
ER-alpha (ERα) is one of the known ER which mediates, at 
least partly, the beneficial effects of E2 on the heart during stress, 
in a genomic or non-genomic manner [15]. ERα is expressed and 
localized in different cardiac cell types of humans and rodents, such 
as cardiomyocytes, fibroblasts and endothelial cells [16-20]. Increased 
expression of ERα could be detected in the heart of patients with aortic 
stenosis and dilated cardiomyopathy, most likely as a compensatory 
mechanism [18,19]. The absence of ERα is associated with the 
increased presence of atherosclerotic plaque in humans, especially in 
premenopausal women [21,22]. In line with these findings, it has been 
demonstrated that ERα-knockout (ERKO) mouse hearts subjected to 
I/R had fewer viable cardiomyocytes, decreased coronary flow rate, 
marked myocardial edema, more prominent mitochondria damage, 
and decreased functional recovery of contractility and compliance 
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Abstract
Experimental studies showed that 17β-estradiol (E2) and activated Estrogen Receptors (ER) protect the heart 
from ischemic injury. However, the underlying molecular mechanisms are not well understood. To investigate the 
role of ER-alpha (ERα) in cardiomyocytes in the setting of myocardial ischemia, we generated transgenic mice 
with cardiomyocyte-specific overexpression of ERα (ERα-OE) and subjected them to Myocardial Infarction (MI). 
At the basal level, female and male ERα-OE mice showed increased Left Ventricular (LV) mass, LV volume and 
cardiomyocyte length. Two weeks after MI, LV volume was significantly increased and LV wall thickness decreased 
in female and male WT-mice and male ERα-OE, but not in female ERα-OE mice. ERα-OE enhanced expression of 
angiogenesis and lymphangiogenesis markers (Vegf, Lyve-1), and neovascularization in the peri-infarct area in both 
sexes. However, attenuated level of fibrosis and higher phosphorylation of JNK signaling pathway could be detected 
only in female ERα-OE after MI. In conclusion, our study indicates that ERα protects female mouse cardiomyocytes 
from the sequelae of ischemia through induction of neovascularization in a paracrine fashion and impaired fibrosis, 
which together may contribute to the attenuation of cardiac remodelling.
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compared with WT-mice [23,24]. By contrast, administration of 
an ERα-selective agonist during Myocardial Infarction (MI) and 
the following phenomenon of I/R injury results in the reduction 
of infarct size, neutrophil infiltration, oxidant stress, necrosis, and 
improvement of myocardial recovery [9,10,25-27]. These data suggest 
that ERα contributes to myocardial salvage after injury, and it is of 
critical importance to understand the relative role of this receptor in 
the heart. However, the activity of ERα is tightly regulated in a cell 
specific manner through complex processes which are still not fully 
understood. Since cardiomyocytes are more susceptible to ischemia 
than other cardiac cell types and their survival determines the outcome 
after myocardial ischemia [28], we aimed to analyze the specific role 
of ERα in cardiomyocytes during ischemia. We therefore generated 
a transgenic mouse model with a cardiomyocyte-specific ERα 
overexpression (ERα-OE) and subjected mice of both sexes to MI. We 
chose a gain of function approach, since it allows us to study the in 
vivo potential role of activation of ERα in cardiomyocytes, which is not 
feasible in a loss of function approach. This study helps to elucidate 
the protective potential of ERα in cardiomyocytes under ischemic 
conditions. Targeted activation of ERα to enhance cardioprotective 




Inducible double transgenic mice with cardiomyocyte-specific 
ERα overexpression (ERα-OE) were generated through mating of 
monotransgenic ERα (tetO-mERα) and monotransgenic α-MHC-tTA 
mice using Tet-Off system (for more details see Material and Methods 
in the supplementary material). Since cardiac phenotype and function 
of monotransgenic tetO-mERα and α-MHC-tTA mice did not 
significantly differ from wild type-littermates (WT, data not shown), 
we did not include the monotransgenic mice in further analysis, and 
only the WT-littermates were used as control. All animal experiments 
were approved by and conducted in accordance with the guidelines set 
out by the State Agency for Health and Social Affairs (LaGeSo, Berlin, 
Germany, G 0360/08) and conform to the Guide for the Care and Use 
of Laboratory Animals published by the US National Institutes of 
health (NIH Publication No. 85-23, revised 1996).
Myocardial infarction model
MI was induced in Female (F) and Male (M) mice at 12 weeks of 
age, by permanent left anterior descending Coronary Artery (LAD) 
ligation. Mice were anesthetized with ketamine hydrochloride (80 
mg/ml)/xylazine hydrochloride (12 mg/ml) solution administered by 
intraperitoneal injection at a dose of 1 mg/kg. Briefly, after intubation, 
LAD coronary artery was ligated with a 7.0 polypropylene suture. As 
non-infarcted controls, mice underwent a sham operation where the 
ligature around the LAD was not tied. Animals were recovered from 
anaesthesia under warming conditions and normal ventilation. The 
animals were treated with rimadyl (5 mg/kg) for analgesia up to 7 days 
post-surgery. Two weeks after MI, animals were sacrificed and hearts 
were harvested for further analysis. To evaluate cardiac function and 
morphology, echocardiography was performed before thoracotomy, 
and 14 days after MI in sedated mice with the echocardiography 
system (Vevo 770 High-Resolution Imaging System, Toronto, Canada) 
equipped with a 20-55 MHz transducer.
Infarct size was determined as described somewhere else [29]. 
Briefly, two-dimensional cineloops from the parasternal long axis 
view were acquired using the EKV™-mode (ECG-Gated Kilohertz 
Visualization), which allows the assessment of cardiac wall motion 
with the highest temporal resolution available in small animal imaging 
today (≅1000 frames per second). For MI size determination, the full 
cardiac cycle was displayed in slow motion in order to clearly identify 
infarcted zones, which were thinned and akinetic. The internal border 
of the infarcted zone (MI border) and the endocardial border of the 
whole LV (LV border) were traced at end-diastole. MI size (in %) was 
calculated as: MI border x 100/LV border.
Isolation of adult mouse ventricular cardiomyocytes and cell 
culture
Ventricular cardiomyocytes were isolated from 2-3 month old 
female and male WT- and ERα-OE mice by a standard enzymatic 
technique as described before [30]. Briefly, animals were anesthetized 
with isoflurane, followed by intraperitoneal injection of 8 µg xylazine 
and 35 µg ketamine. Hearts were rapidly removed and perfused with 
a low Ca2+, collagenease bicarbonate buffer solution (36°C, pH 7.4) 
for 10 min. Subsequently, the ventricles were minced. After several 
wash steps, isolated cardiomyocytes were finally resuspended in M199 
medium (Sigma, Germany) supplemented with 0.2% bovine serum 
albumin, 5% fetal calf serum, 5 mmol/l creatine, 5 mmol/l taurine, 
2 mmol/l carnitine, 10 μmol/l cytosine-D-arabinofuranoside, and 
antibiotics. Cardiomyocytes were seeded in with 0.2% laminin-coated 
4-well chamber slides (Nunc, Wiesbaden-Schierstein, Germany) and 
cultured for 4 h in M199 medium before measurement of their length 
and width.
Cell morphology
The individual length and width of the cardiomyocytes were 
determined on micrographs captured by Axiovert 40 CFL microscope 
(using objective: N-Achroplan 10x/0.25 Ph1 W 0.8) and digitalized by 
AcioCam MR3 camera. Ten micrographs per sample were randomly 
taken, and 100 to 300 rod-shaped myocytes were measured per sex and 
genotype. Length and width of cardiomyocytes were determined at the 
widest point of each myocyte using the software program “AxioVision 
Release 4.8” (Zeiss).
Gene expression analysis
Total RNA isolation and quantitative Real-Time Polymerase 
Chain Reaction (qRT-PCR) was conducted as previously described 
[31]. Quantification of expression levels of the mouse ERα (Esr1), atrial 
natriuretic peptide (Nppa), brain natriuretic peptide (Nppb), myosin 
heavy chain 6 and 7 (Myh6, Myh7), platelet/endothelial cell adhesion 
molecule-1 (Pecam-1 or CD-31), vascular endothelial growth factor 
(Vegf), lymphatic vessel endothelial hyaluronan receptor-1 (Lyve-1), 
collagen type I and III (Col I and Col III) was performed by real time 
PCR, using SYBRGreen (Bio-Rad Laboratories, Hercules, CA, USA). 
The housekeeping gene Hypoxanthine Phosphoribosyltransferase 
(Hprt) was used to normalize the results. Primer sequences used for 
amplification are listed in (Table S1).
Western blot analysis
Western blot analyses were performed using whole LV tissues 
isolated from female and male ERα-OE mice (n ≥ 8) or WT-mice (n 
≥ 8) as previously described [19]. Briefly, for each sample, 25 μg of 
protein was loaded into a 10% polyacrylamide gel, electrophoresed, and 
transferred to a nitrocellulose membrane. Western blot analyses were 
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performed using a standard protocol with specific primary antibodies 
against ERα (G-20, Santa Cruz), phospho-ERα (pERα (serin 118)-R; 
Santa Cruz), mitogen-activated protein kinase c-jun N-terminal kinase 
JNK1/3 (C-17, Santa Cruz), p-JNK (G-7, Santa Cruz), GAPDH (clone 
6C5, Millipore) and donkey anti-mouse IgG or donkey anti-rabbit IgG 
secondary antibody (Jackson Immuno Research Laboratories). Specific 
bands were visualized using ECL™ detection kit (GE Healthcare). Band 
intensities were quantified with ImageJ software 1.37V. 
Histological analysis
After dissection, the transverse midsection of the LV was 
immediately fixed in 4% formaldehyde for 24 h and paraffin-embedded 
for sectioning. Serial tissue sections (3 μm) were cut and routinely 
stained with Hematoxylin-Eosin (H&E) and visualized by light 
microscopy. To analyze the changes in fibrotic areas, LV sections were 
stained with Sirius red to determine collagen deposition. The fibrosis 
area was measured and calculated as the percent of the area of fibrosis 
to entire cross-sectional area of LV by using the Media Cybernetics 
Image Pro PLUS software (Bethesda, MD).
Immunofluorescence analysis
Double-labeling immunofluorescence histochemistry was 
performed as previously described [18]. Briefly, after paraffin-
embedded LV sections (3 μm) were deparaffinized with Neoclear 
(Merck, Germany) and rehydrated to PBS, the sections were subjected 
to heat-mediated antigen retrieval by pressure cooking in 10 mM citric 
acid buffer, pH 6.0. After cooling down to room temperature for 20 min, 
and 1 h of blocking in 1%BSA-PBST (1xPBS+0.2% Tween) at room 
temperature, sections were incubated with primary antibodies against 
CD31 or PECAM-1 ((M-20) SC-1506-R, 1:200 dilution) and against 
LYVE-1 ((Xb-13) SC-80170, 1:50 dilution) overnight at 4°C. After 
washing, sections were incubated with secondary FITC-conjugated 
anti-rabbit IgG (Jackson ImmunoResearch Laboratories) and Cy3-
conjugated anti-rat IgG (Jackson ImmunoResearch Laboratories) both 
at a dilution of 1:100 in 0.1% BSA-PBST for 1 h at RT. Nuclei were 
stained with 6-diamidino-2-phenylindole (DAPI). Finally, sections 
were mounted with VectaShield H-1000 (Linaris) and viewed on an 
upright fluorescence microscope (Olympus BX61). Negative controls 
included sections in which either the primary antibody or secondary 
antibody or both were omitted. In these sections no signals for CD31 
and LYVE-1 were detectable. Quantification of immunoreactivity by 
pixel intensity was analyzed by Image Pro PLUS software (Bethesda, 
MD). The ratio of area of CD31 or LYVE-1 expressing vessels to whole 
LV cross-sectional area was calculated. 
For detection of ERα in the LV sections of WT and ERα-OE mice, 
following antibodies were used: primary antibody anti-ERα (G20, Santa 
Cruz), secondary antibody FITC conjugated goat anti-rabbit (Jackson 
laboratory). Confocal images were acquired using a Leica TCS-SPE 
spectral laser scanning microscope, and images were processed by 
Leica Application Suite AF software (version 1.8.0).
Statistics
All data are presented as mean ± standard error of the means (SEM). 
Statistical analysis was performed using One-way ANOVA followed by 
Bonferroni’s test to compare multiple groups, and two-tailed Student’s 
t-test to compare the mean of two groups. Kaplan–Meier curves were 
created to illustrate cumulative mortality after MI, and statistical 
assessment was performed by the log-rank test. Statistical analyses were 
performed using software Graphpad Prism 5.01. Differences with p ≤ 
0.05 were considered significant.
Results
Characterization of cardiomyocyte-specific ERα overexpress-
ing transgenic mice 
We first evaluated the phenotype of a transgenic mouse model 
with a constitutive cardiomyocyte-specific overexpression of ERα 
(ERα-OE). Overexpression of ERα was detected in the LV tissues of 
ERα-OE mice compared to WT-mice using Western Blotting and 
immunohistochemistry (Figure 1). We found a 10-13 fold increase 
in the expression of ERα transgene 66 kDa isoform in LV-tissues of 
female and male ERα-OE mice (Figure 1A). No sex-differences in 
ERα expression levels were detected. Comparison of ERα expression 
levels in the LV, kidney, liver, uterus and lung of 12 week-old ERα-OE 
mice showed that the ERα overexpression was restricted to the heart 
(Figure 1B). ERα-OE hearts showed a significant increase (3.5-5.0 fold) 
in the phosphorylation level of ERα compared to WT-mice without 
sex-differences (Figure 1C). Immunofluorescence data demonstrated a 
more intense ERα signal in the LV of ERα-OE mice with the strongest 
signal in the nuclei of cardiomyocytes (Figure 1D). 
ERα-overexpression promotes cardiac hypertrophy in the 
basal state in both sexes
Ratio of LV mass to tibia length (LVM/TL) was significantly 
increased in ERα-OE compared to WT-mice in both sexes, 
demonstrating the development of Myocardial Hypertrophy (MH) 
in ERα-OE mice (table 1). This was due to an increase in ventricular 
diastolic and systolic volumes, but not wall thickness in both sexes (table 
1). On microscopic examination of isolated cardiomyocytes, female and 
male ERα-OE displayed a significant increase in cardiomyocyte length, 
but not in cardiomyocyte width compared with WT-mice (Figures 2A-
2C). In line with these data, expression of hypertrophic marker genes 
atrial natriuretic peptide (Nppa) and brain natriuretic peptide (Nppb) 
was significantly increased in the LV of ERα-OE mice (Figures 2D and 
2E). The ratio of myosin heavy chain 7 and 6 (Myh7/Myh6) was shifted 
towards higher expression of the slower Myh7 isoform (Figure 2F). 
These findings overall indicate that cardiomyocyte-specific ERα-OE 
leads to the spontaneous development of cardiac hypertrophy in both 
sexes.
Survival Analysis after myocardial infarction
To investigate the in-vivo potential of ERα overexpression under 
pathological conditions, MI was induced. The mortality was high 
within the first 24 h after MI among all groups without significant 
differences between groups. However, after this acute phase, females 
ERα-OE survived 100%, suggesting that ERα overexpression in female 
hearts increased survival after MI, which was not observed in males 
(Figure 3). Infarct size was similar in both sexes after MI (Table 1). In 
mice overexpressing ERα, infarct size was slightly decreased compared 
to WT mice (Table 1) however the difference was not statistically 
significant.
ERα improves myocardial adaptation after myocardial 
infarction in females
Similar to female and male WT-mice, male ERα-OE mice showed 
significant increase in LV volumes and decrease in wall thickness 
two weeks after MI. In contrast, female ERα-OE hearts showed no 
significant changes in these parameters (Table 1). Cardiac functional 
parameters, such as stroke volume, cardiac output and heart rate, were 
not significantly different between the groups (Table 1). Although both 
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Figure 1: Characterization of ERα-OE mice. (A-C): Representative Western blots demonstrate that A: ERα levels are significantly higher in the LV tissue of female and 
male ERα-OE mice compared to WT-mice, B: ERα protein is overexpressed only in the LV tissue, but not in soleus muscle, uterus, lung and kidney of ERα-OE mice. 
Uterus was used as positive control. C: The phosphorylation level of ERα at Serin-118 is significantly higher in the LV of both female and male ERα-OE mice compared 
to those in WT-mice. GAPDH was used as loading control protein for Western blot analysis and protein normalization. ERα/GAPDH and pERα/GAPDH ratios are 
indicated below each Western blot (A&C). Each bar represents the mean ± SEM (n=7-10 mice per each group). § for the genotype effect (ERα-OE vs. WT, p<0.001). 
D: Immunofluorescence analysis followed by confocal laser microscopy of 3µm paraffin sections revealed higher expression and more intense nuclear localization of 
transgenic ERα (green) in the cardiomyocytes of ERα-OE mice. Nuclei are shown in blue (Dapi). 20x magnification, scale bar 250µm.
female and male ERα-OE mice hearts displayed higher expression of 
molecular MH-indicators (Nppa and Nppb) at the basal level, MI did 
not lead to the further increase in the expression of these genes, as 
observed in WT-mice (Figures 2B and 2C). The hearts of WT-mice of 
both sexes exhibited a significant increase of Myh7/Myh6 ratio after 
MI, which was abolished in female and male ERα-OE mice hearts 
(Figure 2D).
ERα enhances cardiac angiogenesis and lymphangiogenesis 
after myocardial infarction in both sexes
In paraffin-embedded, Hematoxylin-Eosin-stained (H&E) heart 
sections from female and male ERα-OE mice, we observed increased 
occurrence of vascular-like structures predominantly in the peri-infarct 
area. This was found to a lesser extent in the WT-mice of both sexes 
(Figures 4A and 4B). To assess the nature of these vessel-like structures, 
we performed immunofluorescence double staining experiments using 
antibodies against CD-31 (PECAM-1 or) for the staining of blood 
vessel, and against LYVE-1 for the staining of lymphatic vessels. 
Very few CD31 and LYVE-1 positive signals were found in the hearts 
of WT and ERα-OE sham mice (Figures 4C, 4D, 4G and 4H). After 
MI, predominately in the peri-infarct areas and to the lesser extent in 
the infarct areas, the signals for CD31 and LYVE-1 were significantly 
increased in both female and male ERα-OE mice hearts compared to 
their respective sham-operated and to WT controls (Figures 4E, 4F, 4G 
and 4H). Additionally, areas of CD31- and LYVE-1 expressing vessels 
were significantly greater in both female and male ERα-OE mice hearts 
than those in WT-mice hearts after MI (Figures 4E-4H). Consistently, 
the expression of Vegf, a key inducer of angiogenesis, and Lyve-1 were 
significantly increased in tissues obtained from the infarct and peri-
infarct area of female and male ERα-OE mice hearts compared with 
WT-mice (Figures 4I and 4J). Taken together, ERα-overexpression in 
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Figure 2: ERα-overexpression promotes cardiac hypertrophy in the basal state in both sexes. A: Representative micrographs of single cardiomyocytes of WT- and 
ERα-OE mice (40x magnification, scale bar 100µm). B-C: Quantification of diastolic cell length and cardiomyocytes width. Compared to WT, cardiomyocytes isolated 
from female and male ERα-OE displayed a significant increase in diastolic cell length, but no changes in cell width at the basal level. Data are given as mean ± SEM for 
100 to 300 cells per group. § for the genotype effect (ERα-OE vs. WT, p<0.001); * for females vs. males (p<0.001). D-F: Expression analysis of hypertrophy markers. 
D: Nppa, E:Nppb, and F: the ratio of Myh7/Myh6 expression in the LV tissues of female and male ERα-OE mice compared with WT-mice. §for the genotype effect 
(ERα-OE vs. WT, females: p<0.01, p<0.01, p<0.01; males: p<0.001, p<0.001, p<0.01, for each gene). * for MI effect (MI vs. sham, females: p<0.05, p<0.001, p<0.01, 
males: p<0.05, p<0.01, p0.01,for each gene). n≥10.
Figure 3: Comparison of survival curves from female and male ERα-OE and WT mice 2 weeks after MI. In comparison to the other groups, only the female ERα-OE 
mice survived 100% after the acute phase (without first 24h; n=13-17 per group), however this difference was not statistically significant (p=0.209 vs. female WT, by 
log-rank test).
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Figure 4: ERα-overexpression in cardiomyocytes accelerates both angiogenesis and lymphangiogenesis predominantly in the peri-infarct areas in both sexes. A-B: 
Representative images of H&E-stained paraffin sections of LV tissues from WT- and ERα-OE mice after MI. ERα-OE mice hearts showed an increased occurrence of 
vascular-like structures in the peri-infarct area. 20x magnification, scale bar 100µm. C-F: Representative immunofluorescence photographs of LV tissues 2 weeks after 
sham and MI operationfrom WT-(C and E) and ERα-OE (D and F) mice with CD31 and LYVE-1staining (scale bar 100 µm). For a better illustration of CD31 and LYVE-
1 signals, higher magnification of the LV areas with strongest signals, i.e.in the peri-infarct area, have been shown. CD31-positive vessels (green), LYVE-1 positive 
vessels (red), nuclei (DAPI,blue).G-H:Quantification of areas of LYVE-1 and CD31 expressing vessels fromwhole LV cross-sectional areas.Data expressed as mean ± 
SEM of 3 to 4 animals per group. § for the genotype effect: females: p<0.01 (LYVE-1), p<0.01 (CD31); males: p<0.001 (LYVE-1), p<0.01 (CD31). * for MI effect: females: 
p<0.001 (LYVE-1), p<0.05 (CD31); males: p<0.001 (LYVE-1), p<0.05 (CD31). I-J: qRT-PCR analysis of the mRNA levels of Vegf and Lyve-1 in the peri-infarct and 
infarct areas from WT- and ERα-OE mice. Data expressed as mean ± SEM of 5 to 6 animals per group. § for the genotype effect for each gene: females: p<0.05(Vegf) 
and p<0.01 (Lyve-1); males: p<0.05(Vegf)and 0.001 (Lyve-1).
Figure 5: Phosphorylation level of JNK (pJNK) is increased in only female ERα-OE mice hearts. Representative Western blots (top) and bar graph(bottom) representing 
the quantitative Western blot analysis of pJNK in LV tissues from female and male WT and ERα-OE mice. Data are expressed as ratio of pJNK to JNK expression. Bars 
represent the mean ± SEM of 7 to 8 animals per group. § for genotype effect: p<0.01.
Citation: Mahmoodzadeh S, Leber J, Zhang X, Jaisser F, Messaoudi S, et al. (2014) Cardiomyocyte-specific Estrogen Receptor Alpha Increases 
Angiogenesis, Lymphangiogenesis and Reduces Fibrosis in the Female Mouse Heart Post-Myocardial Infarction. J Cell Sci Ther 5: 153. 
doi:10.4172/2157-7013.1000153
Page 7 of 10
Volume 5 • Issue 1 • 1000153J Cell Sci Ther ISSN: 2157-7013 JCEST, an open access journal
cardiomyocytes accelerates both angiogenesis and lymphangiogenesis 
predominantly in the peri-infarct and infarct areas in both sexes.
ERα induces the phosphorylation of JNK signaling pathway 
only in female hearts after myocardial infarction
JNK1/3 is known as a positive regulator of angiogenic process 
[32,33]. Western blot analysis of LV extracts from both female and 
male WT- and ERα-OE mice showed that the phosphorylation level 
of JNK was significantly increased only in female ERα-OE mice hearts 
after MI (Figure 5).
ERα attenuates collagen deposition after myocardial 
infarction only in female hearts
We next determined the effects of ERα overexpression on Col I and 
Col III gene expression and Col deposition in the hearts of ERα-OE 
and WT-mice after MI. Expression of Col I and III were significantly 
increased in the hearts of both female and male WT-mice after MI, but 
not changed in ERα-OE mice (Figures 6A and 6B). Of note, female 
mice with ERα-OE expressed significant less Col I and III than female 
WT-mice after MI. Collagen staining of mid-LV sections from female 
and male WT- and ERα-OE mice showed significant increase of 
collagen deposition in all animals (Figure 6C). However, in line with 
the diminished Col I and III expression, hearts of female ERα-OE mice 
showed significantly less collagen deposition after MI, compared with 
female WT-mice (Figure 6C). Overall, ERα overexpression is associated 
with less fibrosis in female hearts, suggesting that the female hearts are 
less susceptible to MI-induced remodelling.
Discussion
In this study, we present novel insights into mechanisms that 
account for the ERα-dependent myocardial protection against 
myocardial injury, with more beneficial effects in female hearts. Using 
transgenic mice with a cardiomyocyte-specific ERα overexpression, we 
first demonstrated that this was associated with an increase of LVM 
consistent with the increase of cardiomyocyte length at the basal level 
in both female and male mice. After MI, the cardiomyocyte-specific 
ERα-OE inhibited changes in LV-volumes and wall thickness only 
in female mice. These beneficial effects in female ERα-OE hearts 
were associated with increased angiogenesis and lymphangiogenesis, 
attenuated ventricular fibrosis and enhanced JNK phosphorylation. 
Our study indicates that in the female sex, ERα in cardiomyocytes may 
have a therapeutic potential in the treatment of ischemic heart disease, 
leading to more efficient cardiac repair after ischemic injury.
Effects of ERα overexpression on the heart 
To address the effect of ERα more precisely on cardiomyocyte fol-
lowing cardiac injury, we generated mice with a constitutive overex-
pression of ERα in cardiomyocytes. This unique model allows obtain-
ing new insights into ERα mediated Cardioprotective mechanisms. The 
constitutive cardiomyocyte-specific ERα overexpression resulted in 
myocardial hypertrophy, associated with higher LVM, increased ven-
tricular volumes, greater cardiomyocyte length, no fibrosis and aug-
mented expression of hypertrophy-associated genes Nppa and Nppb 
and Myh7/Mhy6 ratio in both sexes at basal level. These are character-
istics of an eccentric type of physiological hypertrophy, and have been 
observed in hearts during pregnancy or in the athlete hearts after en-
durance training [34-37]. The observed effects in our study may be due 
to direct effects of ERα as a transcription factor through the regulation 
of expression of hypertrophy-target genes, or indirect due to hemody-
namic alterations. We demonstrated in this study a higher phosphoryl-
ation of ERα at Ser118, essential for transcriptional activation [38], as 
well as a greater translocation of ERα in the nuclei of ERα-OE mice car-
diomyocytes, pointing to the functional role of ERα as a transcription 
factor in this model. Additionally, in a previous study we showed that 
the expression of hypertrophy-associated genes Nppa, α-actinin and 
Cx43 are increased by E2-induced activation of ERα in a human car-
diomyocyte-like cell line AC16 cells [39]. Therefore, the higher expres-
sion and activation of ERα could be an explanation for the increased 
expression of hypertrophy-associated genes in ERα-OE mice. It is also 
conceivable that the higher expression of Nppa, Nppb and Myh7 in the 
LV of ERα-OE is in response to increased cardiomyocyte stretch due to 
increased cardiomyocyte length, as reported elsewhere [40-43].
Effects of ERα overexpression following myocardial infarction
Following MI, hearts of female ERα-OE mice did not exhibit 
accelerated post-infarct remodelling. Compared to WT and male 
ERα-OE mice, in female ERα-OE hearts systolic and diastolic volumes 
were not increased and LV wall thickness not significantly decreased 
after MI. These phenomena may lead to reduced wall stress in female 
ERα-OE hearts after MI, thus attenuating the adverse consequences of 
remodelling.
Data are means ± SEM. MI: Myocardial Infarction; Sham: sham operation; F: female; M: male; n: number of animals; BW: body weight; TL: tibia length; HW: heart weight; 
LVM: left ventricular (LV) mass; LVW: LV wall thickness; LVVol,d: LV diastolic volume; LVVol,s: LV systolic volume; HR: heart rate; LVSV: LV stroke volume; LVCO: LV 
cardiac output. All data are shown as Mean ± SEM. *p<0.05 MI vs. sham, §p<0.05 ERα-OE vs. WT
Genotype WT-mice ERα-OE mice
















BW [g] 22.03 ± 0.52 21.48 ± 0.54 28.17 ± 0.60 28.58 ± 0.78 22.33 ± 0.52 21.31 ± 0.53 27.64 ± 0.57 27.53 ± 0.75
TL [mm] 16.32 ± 0.13 16.35 ± 0.16 16.86 ± 0.09 16.81 ± 0.16 16.66 ± 0.11 16.39 ± 0.13 16.91 ± 0.10 16.54 ± 0.16
LVM [mg] 84.69 ± 2.97 90.94 ± 1.99 113.97 ± 2.10 121.10 ± 4.31 103.66§ ± 3.22 105.93 ± 4.07 134.98§ ± 5.91 130.90 ± 4.27
LVM/TL [mg/mm] 5.19 ± 0.17 5.57 ± 0.14 6.76 ± 0.13 7.20 ± 0.24 6.23§ ± 0.20 6.46 ± 0.24 7.98§ ± 0.34 7.90 ± 0.23
LVW [mm] 0.63 ± 0.02 0.57* ± 0.01 0.71 ± 0.01 0.62* ± 0.01 0.64 ± 0.01 0.62 ± 0.02 0.73 ± 0.01 0.65* ± 0.02
LVVol,d [µl] 40.90 ± 1.81 67.43* ± 6.64 52.71 ± 2.14 95.77* ± 8.95 59.75§ ± 3.25 74.64 ± 4.76 63.56§ ± 3.52 94.53* ± 5.32
LVVol,s [µl] 14.01 ± 1.26 47.51* ± 6.14 19.98 ± 1,18 67.74* ± 10.72 31.23§ ± 3.24 50.50 ± 6.30 31.63§ ± 2.93 69.40* ± 5.55
HR [bpm] 480.3 ± 14.80 525.5 ± 12.36 495.8 ± 10.12 515.8 ± 12.65 472.5 ± 11.66 459.6 ± 20.26 462.5 ± 20.21 522.3 ± 38.54
LVSV [µl] 26.89 ± 1.31 19.92 ± 1.28 32.73 ± 1.28 28.03 ± 2.35 28.52 ± 1.65 24.14 ± 2.53 31.45 ± 1.90 24.65 ± 3.03
LVCO [ml/min] 13.11 ± 0.86 10.41 ± 0.64 16.16 ± 0.71 14.72 ± 1.39 13.49 ± 1.01 10.25 ± 1.19 15.33 ± 1.13 12.42 ± 1.32
Infarctsize (%) ------- 35.23 ± 3.38 ------- 33.46 ± 3.92 ------- 29.18 ± 3.28 ------- 28.89 ± 3.61
Table 1: Morphological and echocardiographic parameters 2 weeks after sham and MI surgery in female and male WT- and ERα-OE mice.
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With this study, we also provide evidence that cardiomyocyte-
specific ERα overexpression facilitates angiogenesis and lymphangi-
ogenesis (new blood and lymphatic vessels sprouting from pre-existing 
vessels) in the heart in response to MI in both sexes. In this respect, 
the mRNA expression of angiogenesis and lymphangiogenesis markers 
Vegf and Lyve-1, and the area of both CD31- and LYVE-1 expressing 
vessels were significantly increased predominately in the peri-infarct 
and to lesser extent in the infarct area of the hearts from ERα-OE mice. 
This indicates that ERα induces angiogenesis and lymphangiogenesis 
in the heart after MI. Our data are in accordance with other studies 
which provide evidence that the known pro-angiogenic properties 
of E2 [44-48] are mainly mediated by ERα in different tissues under 
normal and pathologic conditions. Angiogenesis is impaired in ERKO 
mice [49-52] or upon ER antagonist-treatment [53] and is increased by 
ERα-agonist [54]. An important molecule that controls angiogenesis 
and lymphangiogenesis in the healing area after MI is VEGF [55-57], 
which can be regulated by E2 in different organs, including the myo-
cardium [44,47,58,59]. It has been speculated that this estrogenic effect 
is most probably mediated through activation of ERα, since the absence 
or deficiency of functional ERα leads to the reduction of expression 
level of Vegf and reduced coronary capillary density in female mouse 
hearts [60,61]. Additionally, it has been reported that E2-activated ER 
inhibits the expression and secretion of Thrombospondin-1, a negative 
regulator of angiogenesis, in human umbilical vein endothelial cells 
through activation of JNK in a non-genomic manner [62]. In line with 
this data we observed an increased phosphorylation of JNK (pJNK) 
only in the hearts of female ERα-OE mice after MI. Therefore, we as-
sume that a higher baseline of endogenous E2 in females, compared 
to males, led to preferential activation of JNK in female ERα-OE car-
diomyocytes. The E2/ERα mediated JNK-activation in this study could 
be either mediated by increased expression of cardiomyocytes-derived 
VEGF in a paracrine manner, as shown in vascular endothelial cells 
[32,33], or demonstrates an additional mechanism independent of 
VEGF in female ERα-OE mice heart.
So far, it is not clear to what extent ERα affects the lymphangiogen-
esis in the heart after MI. To the best of our knowledge, this study is the 
first work that shows the involvement of ERα in the enhancement of 
lymphangiogenesis after MI.
Both angiogenesis and lymphangiogenesis are of clinical interest 
because of their important roles in wound healing and tissue repair. 
Angiogenesis advances delivery of both oxygen and energy substrates 
in peri-infarct and infarct area, and has the potential to salvage 
ischemic myocardium at early stages after MI [63]. Lymphangiogenesis 
Figure 6: Cardiomyocyte-specific overexpression of ERα attenuates fibrosis. A-B: Assessment of mRNA expression of fibrosis markers Col I and III in the LV tissues 
from female and male WT- and ERα-OE mice 2 weeks after sham and MI by qRT-PCR. ERα-OE attenuates the MI-induced expression of Col I and III after MI. Data 
expressed as mean ±SEM; n ≥ 8 mice per group. § for the genotype effect: females: p<0.05 and p<0.01 for each gene. * for MI effect for each gene: WT-female: p<0.001; 
ERα-OE-female: p<0.001;WT-male: p<0.01 and ERα-OE-male p<0.05. C: Sirius red staining of representative LV tissue (upper panel, scale bar 200 µm) and fibrosis 
quantification expressed as the percent of fibrosis area in entire LV cross-section (lower panel) in WT- and ERα-OE mice 2 weeks after sham or MI surgery. The extent 
of interstitial collagen accumulation in female ERα-OE was significantly less in comparison to female WT-mice after MI. Data expressed as mean ± SEM of 4 to 6 
animals per group. § for the genotype effect: p<0.001. * for MI effect (MI vs. sham): WT-female: p<0.001 and ERα-OE-female p<0.01; WT-male: p<0.001 and ERα-OE.
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in the peri-infarct area improves cardiac lymph flow leading to 
reduced lymphedema, thereby reducing a trigger for the development 
of interstitial fibrosis [64-66]. Davis et al. [67] demonstrated in a rat 
model that chronic myocardial edema was accompanied by increased 
mRNA levels of Col I and III followed by significant increases in LV 
collagen deposition. In our study, although both female and male ERα-
OE mice displayed increased angiogenesis and lymphangiogenesis, 
only female ERα-OE mice exhibited significantly reduced expression 
of Col I and III mRNA and less cardiac fibrosis after MI. These data are 
further supported by our recent study showing that ERα is significantly 
involved in the inhibition of cardiac fibrosis in female mice [68]. The 
increased angiogenesis/lymphangiogenesis and attenuated fibrosis 
in female ERα-OE mice following MI could be one explanation 
for the phenomenon that hearts of female ERα-OE mice did not 
exhibit accelerated or adverse post-infarct remodelling, indicated by 
maintained systolic and diastolic volumes and LV wall thickness after 
MI. However, in male ERα-OE mice, despite the higher angiogenesis/
lymphangiogenesis, the activation of JNK-pathway and attenuation of 
fibrosis were not as pronounced as in female ERα-OE mice post MI. 
It seems that in male ERα-OE mice the activation of angiogenesis/
lymphangiogenesis alone is not sufficient to contribute to the improved 
remodeling.
Overall, our data suggests that cardiomyocyte-specific ERα provides 
cardioprotection in female mice by enhancing vascular structure and 
function, and attenuation of cardiac remodeling in a paracrine fashion 
in response to cardiac ischemic injury.
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